Clinical Guideline
Adrenarche
Management of children presenting with
hair/body odour/acne
Includes guidance for the distinction between adrenarche, precocious puberty and
other abnormalities of secondary sexual development
Dr Sarah Kiff
, Consultant Paediatric Endocrinologist, NHS Lothian
Dr Louise Bath
, Consultant in Paediatric Endocrinology and Diabetes, NHS Lothian
Approved by
the SPE
Version 1.1
Date of Issue:
March 2015
Review Date: 08.10.2018
To be reviewed:
08.10.2021
NOTE
This guideline is not intended to be
of all clinical data available for an individual case and are subject to change as scientific knowledge and technology advanc
and patterns of care evolve. Adherence
should they be construed as including all proper methods of care or excluding other acceptable methods of care aimed at the
same results. The ultimate judgement must be m
decisions regarding a particular clinical procedure or treatment plan. This judgement should only be arrived at following
discussion of the options with the patient, covering the di
significant departures from the national guideline or any local guidelines derived from it should be fully documented in the
patient’s case notes at the time the relevant decision is ta
Scottish Paediatric Endocrine
NSDxxxx
-
xxV1
Clinical Guideline
Adrenarche
Management of children presenting with
hair/body odour/acne
Includes guidance for the distinction between adrenarche, precocious puberty and
other abnormalities of secondary sexual development
, Consultant Paediatric Endocrinologist, NHS Lothian
, Consultant in Paediatric Endocrinology and Diabetes, NHS Lothian
the SPE
G Guidelines Group
March 2015
Review Date: 08.10.2018
08.10.2021
This guideline is not intended to be
construed or to serve as a standard of care. Standards of care are determined on the basis
of all clinical data available for an individual case and are subject to change as scientific knowledge and technology advanc
and patterns of care evolve. Adherence
to guideline recommendations will not ensure a successful outcome in every case, nor
should they be construed as including all proper methods of care or excluding other acceptable methods of care aimed at the
same results. The ultimate judgement must be m
ade by the appropriate healthcare professional(s) responsible for clinical
decisions regarding a particular clinical procedure or treatment plan. This judgement should only be arrived at following
discussion of the options with the patient, covering the di
agnostic and treatment choices available. It is advised, however, that
significant departures from the national guideline or any local guidelines derived from it should be fully documented in the
patient’s case notes at the time the relevant decision is ta
ken.
Scottish Paediatric Endocrine
Group
National Managed Clinical
Management of children presenting with
signs of early onset pubic
Includes guidance for the distinction between adrenarche, precocious puberty and
other abnormalities of secondary sexual development
, Consultant Paediatric Endocrinologist, NHS Lothian
, Consultant in Paediatric Endocrinology and Diabetes, NHS Lothian
construed or to serve as a standard of care. Standards of care are determined on the basis
of all clinical data available for an individual case and are subject to change as scientific knowledge and technology advanc
to guideline recommendations will not ensure a successful outcome in every case, nor
should they be construed as including all proper methods of care or excluding other acceptable methods of care aimed at the
ade by the appropriate healthcare professional(s) responsible for clinical
decisions regarding a particular clinical procedure or treatment plan. This judgement should only be arrived at following
agnostic and treatment choices available. It is advised, however, that
significant departures from the national guideline or any local guidelines derived from it should be fully documented in the
National Managed Clinical
Network
signs of early onset pubic
Includes guidance for the distinction between adrenarche, precocious puberty and
, Consultant in Paediatric Endocrinology and Diabetes, NHS Lothian
construed or to serve as a standard of care. Standards of care are determined on the basis
of all clinical data available for an individual case and are subject to change as scientific knowledge and technology advanc
e
to guideline recommendations will not ensure a successful outcome in every case, nor
should they be construed as including all proper methods of care or excluding other acceptable methods of care aimed at the
ade by the appropriate healthcare professional(s) responsible for clinical
decisions regarding a particular clinical procedure or treatment plan. This judgement should only be arrived at following
agnostic and treatment choices available. It is advised, however, that
significant departures from the national guideline or any local guidelines derived from it should be fully documented in the
